Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.010
-0.130 (-6.07%)
At close: Dec 5, 2025, 4:00 PM EST
2.000
-0.010 (-0.50%)
After-hours: Dec 5, 2025, 7:57 PM EST
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $82.91 million as of December 5, 2025. Its market cap has decreased by -65.69% in one year.
Market Cap
82.91M
Enterprise Value
62.92M
1-Year Change
-65.69%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $82.91M, a decrease of -93.78%. That is a compound annual growth rate of -41.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 88.27M | -67.08% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |